Deborah Moshinsky

Deborah Moshinsky is a Director at 1910 Genetics. Deborah has over 20 years of experience in the pharmaceutical and biotech industry. Deborah has a PhD in Biochemistry from MIT and was a Postdoctoral Fellow at Harvard Medical School.

Deborah began their career as a Scientist at Sugen, Inc. where they worked on the development of small molecule kinase inhibitors. Deborah then moved to Pfizer where they led a team of scientists in the discovery and development of new drugs for the treatment of cancer and other diseases.

In 2011, Deborah founded Cell Assay Innovations, a company that provides services and products to the pharmaceutical and biotech industry. Deborah has also served as a Senior Scientific Consultant at Carna Biosciences and as Director of Global R&D at Prestige BioPharma Ltd.

Deborah is an expert in the field of drug discovery and development, and their work has led to the approval of several new drugs by the FDA.

Deborah Moshinsky earned their doctorate in biochemistry from the Massachusetts Institute of Technology. Deborah also holds a degree from Immaculata College.